image
Healthcare - Biotechnology - NASDAQ - US
$ 3.025
-8.79 %
$ 264 M
Market Cap
-2.92
P/E
CASH FLOW STATEMENT
-70 M OPERATING CASH FLOW
-3.90%
-12.4 M INVESTING CASH FLOW
67.33%
164 M FINANCING CASH FLOW
290.92%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Terns Pharmaceuticals, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)20192019202020202021202120222022202320232024202420252025
Net Income -88.9 M
Depreciation & Amortization 896 K
Capital Expenditures -42 K
Stock-Based Compensation 15.6 M
Change in Working Capital 4.38 M
Others 2.66 M
Free Cash Flow -70.1 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
OPERATING CASH FLOW
Net Income (88.9) (90.2) (60.3) (50.2) (40.6) (68.8) (18.0)
Depreciation & Amortization 0.9 0.9 1.0 0.5 0.4 0.2 65 K
Deferred Income Tax 23 K 0.1 0.4 0.2 0.7 0.2 0.3
Stock Based Compensation 15.6 25.5 10.8 8.1 1.7 0.7 0.2
Other Operating Activities (2.1) (5.0) 81 K 0.9 2.9 (0.2) (0.3)
Change in Working Capital 4.4 1.3 (1.0) (1.4) 5.1 1.8 (0.4)
Cash From Operations (70.0) (67.4) (49.1) (41.8) (29.8) (66.2) (18.1)
INVESTING CASH FLOW
Capital Expenditures 42 K 52 K (0.3) (0.3) (0.6) (0.9) (0.2)
Other Items (12.4) (37.9) (22.0) (119.4) 7.3 (3.0) (4.5)
Cash From Investing Activities (12.4) (38.0) (22.3) (119.7) 6.7 (3.9) (4.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 16.9 58 K 58 K
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 1.7 1.0 (0.2) (2.0) 68.6 4 K 99.7
Cash From Financing Activities 164.0 42.0 167.5 134.4 85.5 62 K 99.8
CHANGE IN CASH
Net Change In Cash 81.5 (63.3) 95.5 (27.2) 62.5 (70.1) 77.0
FREE CASH FLOW
Free Cash Flow (70.1) (67.4) (49.4) (42.2) (30.4) (67.1) (18.3)